Nyumbani › Magonjwa ya Uharibifu wa Neva
Majaribio ya kliniki ya Magonjwa ya Uharibifu wa Neva yanayovutia washiriki nchini Marekani
Masomo 32 ya Magonjwa ya Uharibifu wa Neva yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Philadelphia, PAUtafiti 6
- Boston, MAUtafiti 5
- Tampa, FLUtafiti 5
- Orlando, FLUtafiti 5
- San Diego, CAUtafiti 4
- Scottsdale, AZUtafiti 4
- Atlanta, GAUtafiti 4
- San Francisco, CAUtafiti 3
- Gainesville, FLUtafiti 3
- West Palm Beach, FLUtafiti 3
- Denver, COUtafiti 3
- Miami, FLUtafiti 3
- Boca Raton, FLUtafiti 3
- Dallas, TXUtafiti 3
- Farmington Hills, MIUtafiti 3
- Baltimore, MDUtafiti 3
- New York City, NYUtafiti 3
- Los Angeles, CAUtafiti 3
- Chicago, ILUtafiti 3
- Austin, TXUtafiti 3
Kwa jimbo
- ArizonaUtafiti 4
- CaliforniaUtafiti 10
- ColoradoUtafiti 5
- ConnecticutUtafiti 4
- FloridaUtafiti 8
- GeorgiaUtafiti 5
- IllinoisUtafiti 4
- KansasUtafiti 3
- MarylandUtafiti 4
- MassachusettsUtafiti 6
- MichiganUtafiti 4
- New YorkUtafiti 4
- North CarolinaUtafiti 3
- OhioUtafiti 4
- OregonUtafiti 3
- PennsylvaniaUtafiti 6
- TennesseeUtafiti 3
- TexasUtafiti 8
- WashingtonUtafiti 4
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
InaajiriHatua 2
Umri 55 hadi 90 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT06887192The Neurodevelopmental and Behavioral Phenotyping Screening Protocol
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
6 Weeks · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT00271622An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
InaajiriHatua 1/2
6 Months · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT05757141A Study of LY3439539 in Participants With Alzheimer's Disease
InaajiriHatua 1
Umri 50 hadi 85 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT07598370A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
InaajiriHatua 2
Umri 55 hadi 85 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07589595Home Exercise for Individuals With Neurodegenerative Disease
InaajiriWajitolea wenye afya wanakaribishwa
Umri 5 hadi 75 · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT05443906Prenatal Education on Environmental Exposures During Pregnancy Study (PEEPS)
InaajiriWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Wanawake · Imesasishwa 14 Sep 2026 · NCT07758114A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
InaajiriHatua 2
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07804615Observational Pharmaco-Epidemiology Research & Analysis
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 0 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT03813862Parkinson Progression Marker Initiative Online (PPMI Online)
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT05065060Human Observatory Study
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT07646782Biofluid Research on Age-Related or Inherited Neurodegeneration
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Sep 2026 · NCT07798700Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri wote · Jinsia zote · Imesasishwa 1 Sep 2026 · NCT06016946Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Inaajiri
Umri 50 na zaidi · Jinsia zote · Imesasishwa 27 Ago 2026 · NCT06993142A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
InaajiriHatua 1
Umri 50 hadi 85 · Jinsia zote · Imesasishwa 24 Ago 2026 · NCT06297590Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
InaajiriHatua 1
Umri 40 hadi 75 · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT06482268Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
InaajiriHatua 4Wajitolea wenye afya wanakaribishwa
Umri 50 hadi 85 · Jinsia zote · Imesasishwa 7 Ago 2026 · NCT05357612PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 30 na zaidi · Jinsia zote · Imesasishwa 27 Jul 2026 · NCT04477785Imaging Studies in Corticobasal Syndrome
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Jul 2026 · NCT07000851Analysis of Human ALS Tissues and Registry of ALS Patients
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 90 · Jinsia zote · Imesasishwa 8 Jul 2026 · NCT05067179Neurologic Stem Cell Treatment Study
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 26 Jun 2026 · NCT02795052Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
InaajiriWajitolea wenye afya wanakaribishwa
Umri 40 na zaidi · Jinsia zote · Imesasishwa 10 Jun 2026 · NCT05741853F 18 T807 Tau PET Imaging of Alzheimer's Disease
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Jun 2026 · NCT02414347Intraneural Administration of scAAV9/JeT-GAN Into the Vagus Nerve for Patients With Giant Axonal Neuropathy (GAN)
InaajiriHatua 1
Umri 10 hadi 25 · Jinsia zote · Imesasishwa 22 Apr 2026 · NCT07543991Intervention for Communication Quality of Life in Primary Progressive Aphasia
Inaajiri
Umri 40 na zaidi · Jinsia zote · Imesasishwa 21 Apr 2026 · NCT07219680Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.